Immunogenicity of indigenous recombinant hepatitis B vaccine in infants following a 0, 1, 2-month vaccination schedule

Indian Pediatr. 2000 Jan;37(1):75-80.

Authors

T S Kumar¹, P Abraham, S Raghuraman, T Cherian

Affiliation

¹ Department of Child Health, Christian Medical College and Hospital, Vellore 632 004, Tamil Nadu, India.

PMID: 10745392

No abstract available

Publication types

Clinical Trial
Comparative Study
Research Support, Non-U.S. Gov't

MeSH terms

Consumer Product Safety
Diphtheria-Tetanus-Pertussis Vaccine / pharmacology
Hepatitis B / immunology
Hepatitis B / prevention & control*
Hepatitis B Vaccines / pharmacology
Hepatitis B Vaccines / therapeutic use*
Humans
Immunization Schedule
Infant
Infant, Newborn
Vaccines, Synthetic / pharmacology
Vaccines, Synthetic / therapeutic use*

Substances

Diphtheria-Tetanus-Pertussis Vaccine
Hepatitis B Vaccines
Vaccines, Synthetic